COVID-19 Vaccine Inhaled Through the Mouth Launched in China

WEDNESDAY, Oct. 26, 2022 (HealthDay News) -- China announced Wednesday that it has started giving its citizens a COVID-19 booster that can be inhaled through the mouth.
The oral vaccine was distributed in Shanghai. A video appeared on Chinese state media, showing people holding a translucent white cup with a short nozzle to their mouths. Text accompanying the video said a person slowly inhaled the mist, held his breath for five seconds and was finished within 20 seconds, the Associated Press reported.
An inhaled vaccine could appeal to someone afraid of needles, and the concept of priming the area of the body where the virus often enters is another advantage. Vineeta Bal, M.D., an immunologist in India, said large droplets would prime the mouth and throat. Small droplets would travel further into the body, the AP reported.
The vaccine was developed by CanSino Biologics, a Chinese biopharmaceutical company, and is an aerosol version of the company's one-shot adenovirus vaccine. It was approved in September by Chinese regulators after completing trials in China, Hungary, Pakistan, Malaysia, Argentina, and Mexico, the AP reported. It was offered as a booster dose for people who had already received initial vaccines, according to an announcement posted on an official Shanghai social media account.
An earlier nasal vaccine, developed in the United States, has been approved by regulators in India but has not been distributed yet. It is licensed to Indian vaccine maker Bharat Biotech, the AP reported. Other nasal vaccines are being tested globally, according to the World Health Organization.
Related Posts
La muerte de Powell, que estaba vacunado, por COVID resalta el peligro para las personas inmunocomprometidas
LUNES, 18 de octubre de 2021 (HealthDay News) -- Colin Powell, la primera...
Climate Change Could Bring Rising Obesity Rates
THURSDAY, Oct. 14, 2021 (HealthDay News) -- You can add obesity and its related...
Adherence to Mediterranean Diet Linked to Lower CVD, Mortality in Women
WEDNESDAY, March 15, 2023 (HealthDay News) -- For women, adherence to a...
Unos nuevos datos confirman que el refuerzo actualizado de Pfizer se dirige a las variantes ómicron
VIERNES, 14 de octubre de 2022 (HealthDay News) -- Los datos de un nuevo ensayo...
